Menu Search
Equities

Takeda Pharmaceutical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
TKDA:DUS

Takeda Pharmaceutical Co Ltd

Actions
  • Price (EUR)15.30
  • Today's Change0.10 / 0.66%
  • Shares traded--
  • 1 Year change+17.69%
  • Beta0.0388
Data delayed at least 15 minutes, as of Feb 16 2026 07:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2025202520242023
REVENUE AND GROSS PROFIT
Total revenue4,581,5514,263,7624,027,478
OPERATING EXPENSES
Cost of revenue total1,580,2171,426,6781,244,072
Selling, general and admin. expenses, total1,104,7661,053,819997,309
Depreciation/amortization548,186521,525542,443
Unusual expense(income)212,118216,71260,390
Other operating expenses, total63,451101,02959,434
Total operating expense4,238,9654,049,6873,536,973
Operating income342,586214,075490,505
Other, net01.00--
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes175,08452,791375,090
Provision for income taxes66,941(91406)58,052
Net income after taxes108,143144,197317,038
Minority interest(215)(130)(21)
Net income before extra. Items107,928144,067317,017
Total extraordinary items------
Net income107,928144,067317,017
Inc.avail. to common excl. extra. Items107,928144,067317,017
Inc.avail. to common incl. extra. Items107,928144,067317,017
EPS RECONCILIATION
Basic/primary weighted average shares1,5791,5641,552
Basic/primary eps excl. extra items6892204
Basic/primary eps incl. extra items6892204
Dilution adjustment------
Diluted weighted average shares1,5791,5641,570
Diluted eps excl. extra items6892202
Diluted eps incl. extra items6892202
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock310,656296,078280,949
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental137,311119,535116,973
SUPPLEMENTAL INCOME
Depreciation, supplemental173,392170,339150,379
Total special items212,118216,71260,390
NORMALISED INCOME
Normalized income before taxes387,202269,503435,480
Effect of special items on income taxes81,10075,8499,346
Income tax excluding impact of special items148,041(15557)67,398
Normalized income after tax239,161285,060368,082
Normalized income avail. to common238,946284,930368,061
Basic normalized EPS151182237
Diluted normalized EPS151182234
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.